| Description | Pharmaceutical company focusing on therapeutic areas with high unmet patient needs and technological platform development |
| Citation(s) | |
| Acronym | NIBR |
| External Link | https://zenodo.org/records/14291446 |
| Dataset | Description | Category | Attribute | Views |
|---|---|---|---|---|
| DRUG-seq U2OS MoA Box | Drug perturbation signatures created by profiling 4343 small molecules in the U2-OS cell line with the DRUG-seq platform | transcriptomics | drug perturbation | 112 |
